The Singapore Ministry of Health (MOH) renewed Cordlife's (SGX:P8A) license to provide its cord bank and human tissue banking services with effect from Jan. 14, according to a same-day filing with the Singapore Exchange.
The license has been renewed for a period of one year.
In an earlier filing, the company said it was able to resume its operations in a controlled manner and was not allowed to collect, test, process and store more than 30 units per month of new cord blood from infant donors until Jan. 13.
Shares of the company surged nearly 14% in recent trading.
Price (SGD): S$0.17, Change: S$+0.020, Percent Change: +13.79%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。